Description

medicine.

Description

Linjardy 5/10mg is a fixed-dose combination tablet that brings together two distinct classes of anti-diabetic medicine, packaged 14 tablets to a pack. It pairs Linagliptin, a DPP-4 inhibitor that helps the pancreas release more insulin around mealtimes while also reducing the amount of glucose the liver produces, with Empagliflozin, an SGLT2 inhibitor that works separately by prompting the kidneys to remove excess glucose through urine. Because the two ingredients act on entirely different systems, one on insulin-related pathways and the other on the kidneys, combining them into a single tablet allows for a broader, multi-angle approach to blood sugar control, often used when a single mechanism alone isn’t achieving the desired result.

Ingredients

Each Linjardy 5/10mg tablet contains:

• Linagliptin – 5 mg
• Empagliflozin – 10 mg

The tablet also contains standard inactive excipients and a film coating, included only to support the tablet’s structure and ease of swallowing, without any therapeutic effect of their own.

Dosage Form

Linjardy 5/10mg is manufactured as a film-coated oral tablet, supplied 14 tablets per pack, taken by mouth once daily as directed by a physician.

Uses

Linjardy 5/10mg is generally prescribed to:

• Improve blood glucose control in adults with type 2 diabetes mellitus, alongside a suitable diet and regular exercise
• Support patients who need both insulin-pathway support and kidney-based glucose clearance for adequate glycemic control
• Help reduce the long-term risk of cardiovascular complications associated with poorly controlled type 2 diabetes, when used as part of an overall treatment plan

It is not intended for people with type 1 diabetes or for the management of diabetic ketoacidosis.

How to Use

The following points are general guidance only — always follow the specific instructions given by your prescribing doctor:

• Take one tablet by mouth once daily, generally in the morning, with or without food.
• Try to take the dose at the same time each day to help maintain steady blood sugar control.
• Swallow the tablet whole with a glass of water; do not crush or chew it unless specifically advised otherwise.
• Continue regular blood sugar monitoring as instructed by your healthcare provider, since medication works alongside, not instead of, lifestyle management.
• If a dose is missed, take it as soon as remembered unless it is almost time for the next dose, in which case skip the missed one rather than doubling up.

Side Effects

Some patients tolerate Linjardy well, while others may notice side effects such as:

• Increased urination
• Mild dehydration or increased thirst
• Urinary tract or genital yeast infections
• Upper respiratory symptoms such as a runny or stuffy nose
• Mild digestive discomfort, including nausea or diarrhea

Less commonly, more serious effects can occur, including a noticeable drop in blood pressure, signs of pancreatitis such as persistent abdominal pain, or symptoms suggesting diabetic ketoacidosis such as ongoing nausea, vomiting, or abdominal discomfort even when blood sugar readings appear normal. Joint pain has also been reported in some patients taking DPP-4 inhibitors like Linagliptin. Any of these symptoms should prompt medical attention. This list is not exhaustive, so any unusual or persistent symptom should be discussed with a doctor or pharmacist.

Pregnancy & Breastfeeding

Linjardy is generally not recommended during pregnancy, particularly from the second trimester onward, as the Empagliflozin component may affect fetal kidney development. It is also not typically advised while breastfeeding, since safety data for both components in this setting is limited. Women who are pregnant, planning to become pregnant, or currently breastfeeding should inform their doctor before starting this medication, so that a more suitable alternative treatment can be considered if needed.

Storage Instructions

• Store Linjardy tablets at room temperature, ideally below 25°C, away from direct sunlight, heat, and humidity.
• Keep tablets in their original blister packaging until they are ready to be used.
• Store out of reach of children.
• Do not use tablets past their printed expiry date, and dispose of unused medicine responsibly rather than through household waste.

FAQS

How is Linjardy different from Jardy-Met?
Linjardy combines Empagliflozin with Linagliptin, a DPP-4 inhibitor, while Jardy-Met combines Empagliflozin with Metformin; the two combinations work through different secondary mechanisms and may suit different patients.

Can Linjardy cause low blood sugar on its own?
Used alone, the risk of hypoglycemia is relatively low, but it increases when combined with insulin or sulfonylurea medications, so your doctor will monitor this closely if you’re on multiple treatments.

Does Linjardy help with weight management?
Some patients notice modest weight reduction while taking this combination, largely related to the glucose lost through urine via the Empagliflozin component.

Why might my doctor mention joint pain as a possible side effect?
Joint pain has been reported in some patients taking Linagliptin and other DPP-4 inhibitors; if it becomes persistent or severe, it should be discussed with your doctor.

Is Linjardy suitable for someone with reduced kidney function?
Suitability depends on the degree of kidney impairment, since the Empagliflozin component relies on adequate kidney function; your doctor will assess this before prescribing.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.